TickerFacts.

Iqvia Holdings Inc. (IQV): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

$2.05B
Year ended 2025-12-31
$2.12B
Trailing 12 months to 2026-03-31
+8.9%
3-year compound annual growth
+8.8%
5-year compound annual growth
+17.8%
10-year compound annual growth
$2.30B2011-12-31: $85.27M2012-12-31: $264.37M2013-12-31: $305.02M2014-12-31: $350.00M2015-12-31: $398.00M2016-12-31: $696.00M2017-12-31: $601.00M2018-12-31: $795.00M2019-12-31: $835.00M2020-12-31: $1.34B2021-12-31: $2.30B2022-12-31: $1.59B2023-12-31: $1.50B2024-12-31: $2.11B2025-12-31: $2.05B$2.05B
2011-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$2.05B-3.0%2026-02-17, From 2025-01-01
2024-12-31$2.11B+40.9%2026-02-17, From 2024-01-01
2023-12-31$1.50B-5.4%2026-02-17, From 2023-01-01
2022-12-31$1.59B-31.1%2025-02-13, From 2022-01-01
2021-12-31$2.30B+71.4%2024-02-15, From 2021-01-01
2020-12-31$1.34B+60.8%2023-02-15, From 2020-01-01
2019-12-31$835.00M+5.0%2022-02-16, From 2019-01-01
2018-12-31$795.00M+32.3%2021-02-12, From 2018-01-01
2017-12-31$601.00M-13.6%2020-02-18, From 2017-01-01
2016-12-31$696.00M+74.9%2019-02-19, From 2016-01-01
2015-12-31$398.00M+13.7%2018-02-16, From 2015-01-01
2014-12-31$350.00M+14.7%2017-02-16, From 2014-01-01
2013-12-31$305.02M+15.4%2016-02-11, From 2013-01-01
2012-12-31$264.37M+210.0%2015-02-12, From 2012-01-01
2011-12-31$85.27Mn/a2014-02-13, From 2011-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Iqvia Holdings Inc. (IQV)2025-12-31$2.05B-3.0%
Icon PLC (ICLR)2025-12-31$861.99M-22.9%
Charles River Laboratories International, Inc. (CRL)2025-12-27$518.49M+3.4%
Medpace Holdings, Inc. (MEDP)2025-12-31$681.87M+19.2%
NRC Health (NRC)2025-12-31$15.74M-17.9%
MaxCyte, Inc. (MXCT)2025-12-31-$36.18Mn/m
OmniAb, Inc. (OABI)2025-12-31-$37.02Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$3.93Mn/a
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$9.39Mn/m

Compare IQV, ICLR, CRL, MEDP side by side · Screen every company in Services-Commercial Physical & Biological Research ↗